In this second part of his interview, Professor David F Chang discusses his recent study which was presented at AAO 2018 – “Endophthalmitis Reduction with Intracameral Moxifloxacin After Posterior Capsule Rupture”. This 6-year retrospective study involving more than 1,540,000 consecutive cases of cataract surgery, half of which had intracameral moxifloxacin, which lowered the infection rate from 7/10,000 to 2/10,000. They also investigated the effect of posterior capsule rupture with and without intracameral moxifloxacin and found that the use of intracameral antibiotic was very effective. He then touches on the effect of climate change regulations on the updated guidelines for the cleaning, sterilization and reuse of ophthalmic tools.
Questions:
1. Tell us about your recent study: “Endophthalmitis Reduction with Intracameral Moxifloxacin After Posterior Capsule Rupture” (0:11)
2. Using fewer resources is of increasing concern in the light of evidence of climate change. How is this addressed in the new guidelines? (2:10)
Speaker disclosures: David Chang has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
